针对1型糖尿病幼儿的学校合作护理干预:试点和可行性协议
Christine March1, Scott Rothenberger2, Elissa Naame3
1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America; Pediatric Endocrinology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, United States of America.
Contemporary clinical trials
|February 18, 2026
概括
一个新的以学校为基础的计划,T1D的空间,在改善1型糖尿病儿童的血糖控制方面显示出希望. 本试点研究评估其可行性和可接受性,以支持学生进行慢性疾病管理.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 慢性疾病管理 慢性疾病管理
- 医疗保健服务研究 医疗服务研究
背景情况:
- 患有1型糖尿病的儿童往往难以达到血糖目标,尽管治疗进展.
- 在医疗保健系统和学校之间协调护理对儿童慢性疾病的管理构成了重大挑战.
- 参与家长,学校护士和糖尿病专家的协作护理模式可能会改善护理协调.
研究的目的:
- 评估学校合作合作护理模式 (T1D的空间) 在不同学区的可行性和可接受性.
- 评估SPACE对T1D干预措施对1型糖尿病儿童健康和学业成果的潜在影响.
- 根据学校的慢性疾病管理干预措施进行全面试验的设计,提供信息.
主要方法:
- 一个试点集群随机试验,涉及1型糖尿病的5-12岁儿童.
- 将学区随机划分为T1D干预的SPACE或增强的常规护理.
- 通过家长和学校护士问卷评估可行性,可接受性,适当性和可用性;探索性结果包括血糖控制和生活质量.
主要成果:
- 11个学区参加了一次学后,在46名接近的学生中,有30名学生同意 (65%的招聘率).
- 该研究在多个学区成功启动了T1D干预的SPACE.
- 开始收集关于可行性,可接受性和探索性结果的数据.
结论:
- 针对T1D的SPACE干预措施在各种学校环境中是可行的和可接受的.
- 这些发现支持在更大,更强大的试验中进行进一步调查,以确定健康和学术效益.
- 这项研究有助于建立基于学校的干预措施的证据基础,支持患有慢性疾病的年轻人.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
393
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
393
Diabetes Mellitus: Overview and Type I Subtype
5.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
Insulin: Dosing Regimen and Adverse Effects
874
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
874
Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Community Based Intervention
498
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
498
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K


